NPY and Insulin resistance: Overexpression of NPY in mice has been reported to cause the obesity phenotype and insulin resistance, leading to a series of metabolic disorders [19], while the use of NPY antagonists has been found to reduce obesity and metabolic imbalances in fat tissue associated with aging [17].